Carboxylic acid (bio) isosteres in drug design

C Ballatore, DM Huryn, AB Smith III - ChemMedChem, 2013 - Wiley Online Library
The carboxylic acid functional group can be an important constituent of a pharmacophore,
however, the presence of this moiety can also be responsible for significant drawbacks …

Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer's disease

YJ Cheng, CH Lin, HY Lane - International Journal of Molecular Sciences, 2021 - mdpi.com
Alzheimer's disease (AD), the most common cause of dementia, is a progressive
neurodegenerative disease. The number of AD cases has been rapidly growing worldwide …

[图书][B] Microwave heating as a tool for sustainable chemistry

NE Leadbeater - 2010 - taylorfrancis.com
Shorter reaction times, higher product yields, and enhanced selectivity are some of the
advantages microwave heating has over conventional methods, causing its use to transition …

Human D-amino acid oxidase: structure, function, and regulation

L Pollegioni, S Sacchi, G Murtas - Frontiers in Molecular Biosciences, 2018 - frontiersin.org
D-Amino acid oxidase (DAAO) is an FAD-containing flavoenzyme that catalyzes with
absolute stereoselectivity the oxidative deamination of all natural D-amino acids, the only …

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia

L Verrall, PWJ Burnet, JF Betts, PJ Harrison - Molecular psychiatry, 2010 - nature.com
D-amino acid oxidase (DAO) is a flavoenzyme that metabolizes certain D-amino acids,
notably the endogenous N-methyl D-aspartate receptor (NMDAR) co-agonist, D-serine. As …

New biotech applications from evolved D-amino acid oxidases

L Pollegioni, G Molla - Trends in biotechnology, 2011 - cell.com
d-Amino acid oxidase (DAAO) is a well-known flavoenzyme that catalyzes the oxygen-
dependent oxidative deamination of amino acid D-isomers with absolute stereospecificity …

Directly and indirectly targeting the glycine modulatory site to modulate NMDA receptor function to address unmet medical needs of patients with schizophrenia

JC Pei, DZ Luo, SS Gau, CY Chang, WS Lai - Frontiers in Psychiatry, 2021 - frontiersin.org
Schizophrenia is a severe mental illness that affects~ 1% of the world's population. It is
clinically characterized by positive, negative, and cognitive symptoms. Currently available …

The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia

V Labrie, JC Roder - Neuroscience & Biobehavioral Reviews, 2010 - Elsevier
Hypofunction of the N-methyl-d-aspartate receptor (NMDAR) has been implicated in the
pathophysiology of schizophrenia. The NMDAR contains a d-serine/glycine site on the NR1 …

Rational and translational implications of D-amino acids for treatment-resistant schizophrenia: from neurobiology to the clinics

A de Bartolomeis, L Vellucci, MC Austin, G De Simone… - Biomolecules, 2022 - mdpi.com
Schizophrenia has been conceptualized as a neurodevelopmental disorder with synaptic
alterations and aberrant cortical–subcortical connections. Antipsychotics are the mainstay of …

Contributions of the D-serine pathway to schizophrenia

V Labrie, AHC Wong, JC Roder - Neuropharmacology, 2012 - Elsevier
The glutamate neurotransmitter system is one of the major candidate pathways for the
pathophysiology of schizophrenia, and increased understanding of the pharmacology …